These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 36225931)

  • 1. A novel neutrophil extracellular trap signature to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma.
    Li Q; Chen W; Li Q; Mao J; Chen X
    Front Immunol; 2022; 13():1019967. PubMed ID: 36225931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance.
    Han Y; Shi Y; Chen B; Wang J; Liu Y; Sheng S; Fu Z; Shen C; Wang X; Yin S; Li H
    Front Immunol; 2022; 13():961695. PubMed ID: 36389709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an endoplasmic reticulum stress-related signature with potential implications in prognosis and immunotherapy in head and neck squamous cell carcinoma.
    Fan X; Yang X; Guo N; Gao X; Zhao Y
    Diagn Pathol; 2023 Apr; 18(1):51. PubMed ID: 37087456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the prognosis, immune response, and immunotherapy in head and neck squamous cell carcinoma using a novel risk model based on anoikis-related lncRNAs.
    Deng H; Wei Z; Du J; Shen Z; Zhou C
    Eur J Med Res; 2023 Nov; 28(1):548. PubMed ID: 38017579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere maintenance genes-derived prognosis signature characterizes immune landscape and predicts prognosis of head and neck squamous cell carcinoma.
    Zou J; Chu S; Bao Q; Zhang Y
    Medicine (Baltimore); 2023 Aug; 102(31):e34586. PubMed ID: 37543795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of molecular classification and gene signature for predicting prognosis and immunotherapy response in HNSCC using cell differentiation trajectories.
    Yin J; Zheng S; He X; Huang Y; Hu L; Qin F; Zhong L; Li S; Hu W; Zhu J
    Sci Rep; 2022 Nov; 12(1):20404. PubMed ID: 36437265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the immune cell function landscape in head and neck squamous carcinoma to assist in prognosis prediction and immunotherapy.
    Wang W; Zhang Z; Li W; Wei D; Xu J; Qian Y; Cao S; Lei D
    Aging (Albany NY); 2023 Nov; 15(21):12588-12617. PubMed ID: 37955651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A predictive model of immune infiltration and prognosis of head and neck squamous cell carcinoma based on cell adhesion-related genes: including molecular biological validation.
    Liu Y; Wu Z; Fu Z; Han Y; Wang J; Zhang Y; Liang B; Tao Y; Zhang Y; Shen C; Xu Y; Yin S; Chen B; Liu Y; Pan H; Liang Z; Wu K
    Front Immunol; 2023; 14():1190678. PubMed ID: 37691922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive investigation into the influence of glycosylation on head and neck squamous cell carcinoma and development of a prognostic model for risk assessment and anticipating immunotherapy.
    Ma H; Xiong L; Zhao B; Hahan Z; Wei M; Shi H; Yang S; Ren Q
    Front Immunol; 2024; 15():1364082. PubMed ID: 38562924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity.
    Chi H; Yang J; Peng G; Zhang J; Song G; Xie X; Xia Z; Liu J; Tian G
    Front Immunol; 2023; 14():1091218. PubMed ID: 36969232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of two distinct head and neck squamous cell carcinoma subtypes based on fatty acid metabolism-related signatures: Implications for immunotherapy and chemotherapy.
    Zou J; Dai Y; Xu G; Kai Y; Lan L; Zhang J; Wang Y
    Medicine (Baltimore); 2024 Apr; 103(16):e37824. PubMed ID: 38640298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC.
    Chi H; Xie X; Yan Y; Peng G; Strohmer DF; Lai G; Zhao S; Xia Z; Tian G
    Front Immunol; 2022; 13():1018685. PubMed ID: 36263048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma.
    Shen A; Ye Y; Chen F; Xu Y; Zhang Z; Zhao Q; Zeng ZL
    Front Immunol; 2022; 13():969034. PubMed ID: 36466881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the Immune Microenvironment and Prognosis with a NETosis-Related lncRNA Signature in Head and Neck Squamous Cell Carcinoma.
    He X; Xiao Y; Liu S; Deng R; Li Z; Zhu X
    Biomed Res Int; 2022; 2022():3191474. PubMed ID: 36147630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cell marker gene signature in head and neck squamous cell carcinoma.
    Cai Z; Tang B; Chen L; Lei W
    BMC Cancer; 2022 May; 22(1):577. PubMed ID: 35610596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma.
    Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C
    J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma.
    Huang Y; Liu H; Liu B; Chen X; Li D; Xue J; Li N; Zhu L; Yang L; Xiao J; Liu C
    BMC Med Genomics; 2024 Feb; 17(1):49. PubMed ID: 38331768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular subtyping and prognostic risk characterization of head and neck squamous cell carcinoma based on lysosome-related genes.
    Zhang A; Jin Y; Zou X; Zhang S
    Medicine (Baltimore); 2023 Jul; 102(28):e34275. PubMed ID: 37443469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Wei Z; Shen Y; Zhou C; Cao Y; Deng H; Shen Z
    Bioengineered; 2022 May; 13(5):13784-13800. PubMed ID: 35712757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.